Professor Charles R M Bangham

Publications


Journals

  • Tattermusch S; Skinner JA; Chaussabel D; Banchereau J; Berry MP; McNab FW; O'Garra A; Taylor GP; et alBangham CR. (Jan 2012). Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog. 8:e1002480. DOI.
  • Berry CC; Gillet NA; Melamed A; Gormley N; Bangham CR; Bushman FD. (15 Mar 2012). Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics. 28:755-762. DOI.
  • Martin F; Bangham CR; Ciminale V; Lairmore MD; Murphy EL; Switzer WM; Mahieux R. (2011). Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium. Retrovirology. 8:86. DOI.
  • Kirk PDW; Witkover A; Courtney A; Lewin AM; Wait R; Stumpf MPH; Richardson S; Taylor GP; et alBangham CRM. (12 Oct 2011). Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology. 8.
  • Seich al Basatena NK; MacNamara A; Vine AM; Thio CL; Astemborski J; Usuku K; Osame M; Kirk GD; et alDonfield SM; Goedert JJ; Bangham CRM; Carrington M; Khakoo SI; Asquith B. (13 Oct 2011). KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathogens. 7.
  • Bangham CRM; Toulza F. VandeWoude GF (ed); Klein G (ed). (1 Jan 2011). Adult T Cell Leukemia/Lymphoma: FoxP3(+) Cells and the Cell-Mediated Immune Response to HTLV-1. ADVANCES IN CANCER RESEARCH, VOL 111. 111:163-182. Author weblink DOI.
  • Villaudy J; Wencker M; Gadot N; Gillet NA; Scoazec JY; Gazzolo L; Manz MG; Bangham CR; et alDodon MD. (Sep 2011). HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice. PLoS Pathog. 7:e1002231. DOI.
  • Thomas S; Xue SA; Bangham CR; Jakobsen BK; Morris EC; Stauss HJ. (14 Jul 2011). Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen. Blood. 118:319-329. DOI.
  • Bangham CR; Toulza F. (2011). Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1. Adv Cancer Res. 111:163-182. DOI.
  • Rende F; Cavallari I; Corradin A; Silic-Benussi M; Toulza F; Toffolo GM; Tanaka Y; Jacobson S; et alTaylor GP; D'Agostino DM; Bangham CR; Ciminale V. (5 May 2011). Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood. 117:4855-4859. DOI.
  • Hilburn S; Rowan A; Demontis MA; MacNamara A; Asquith B; Bangham CR; Taylor GP. (15 Feb 2011). In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis. 203:529-536. DOI.
  • Gillet NA; Malani N; Melamed A; Gormley N; Carter R; Bentley D; Berry C; Bushman FD; et alTaylor GP; Bangham CR. (17 Mar 2011). The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 117:3113-3122. DOI.
  • Macnamara A; Rowan A; Hilburn S; Kadolsky U; Fujiwara H; Suemori K; Yasukawa M; Taylor G; et alBangham CR; Asquith B. (2010). HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 6:e1001117. DOI.
  • Nejmeddine M; Bangham CRM. (1 Jul 2010). The HTLV-1 Virological Synapse. VIRUSES-BASEL. 2:1427-1447. DOI.
  • Afonso PV; Mekaouche M; Mortreux F; Toulza F; Moriceau A; Wattel E; Gessain A; Bangham CR; et alDubreuil G; Plumelle Y; Hermine O; Estaquier J; Mahieux R. (11 Nov 2010). Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood. 116:3802-3808. DOI.
  • Cloke TE; Garvey L; Choi BS; Abebe T; Hailu A; Hancock M; Kadolsky U; Bangham CR; et alMunder M; Müller I; Taylor GP; Kropf P. (15 Aug 2010). Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. J Infect Dis. 202:374-385. DOI.
  • BANGHAM CRM. (1 Apr 1995). THE ETHICAL DIMENSIONS OF THE BIOLOGICAL SCIENCES - BULGER,RE, HEITMAN,E, REISER,SJ. JOURNAL OF MEDICAL ETHICS. 21:121-122. Author weblink DOI.
  • Bangham CRM; Kermode AG; Hall SE; Daenke S. (1 Feb 1996). The cytotoxic T-lymphocyte response to HTLV-I: The main determinant of disease?. SEMINARS IN VIROLOGY. 7:41-48. Author weblink DOI.
  • Bangham CRM; McMichael AJ. (1 Feb 1996). Presentation of viral antigens to cytotoxic T cells - Introduction. SEMINARS IN VIROLOGY. 7:1-2. Author weblink DOI.
  • Jeffery KJM; Bangham CRM. (1 Apr 1996). Recent advances in the laboratory diagnosis of central nervous system infections. CURRENT OPINION IN INFECTIOUS DISEASES. 9:132-137. Author weblink DOI.
  • Bangham CRM. (1 Oct 1996). Ethics and biotechnology - Dyson,A, Harris,J. JOURNAL OF MEDICAL ETHICS. 22:316-317. Author weblink DOI.
  • Bangham CRM; May RM; Nowak MA. (29 Aug 2000). The dynamics of virus infections - Papers of a Discussion Meeting organized and edited by C. R. M. Bangham, R. M. May and M. A. Nowak - Meeting held on 19 and 20 January 2000 - Preface. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES. 355:1005-1005. Author weblink.
  • BANGHAM CRM; VEALE KEA. (1 Jan 1977). VENTILATORY CAPACITY IN HEALTHY NEPALESE. JOURNAL OF PHYSIOLOGY-LONDON. 265:P31-P32. Author weblink.
  • BANGHAM CRM; SACHERER JM. (1 Jan 1981). FERTILITY OF NEPALESE SHERPAS AT MODERATE ALTITUDES - COMPARISONS WITH HIGH-ALTITUDE DATA - REPLY. ANNALS OF HUMAN BIOLOGY. 8:385-386. Author weblink.
  • BANGHAM CRM; NIGHTINGALE S; CRUICKSHANK JK; DAENKE S. (10 Nov 1989). PCR ANALYSIS OF DNA FROM MULTIPLE-SCLEROSIS PATIENTS FOR THE PRESENCE OF HTLV-I. SCIENCE. 246:821-821. Author weblink.
  • Pichler K; Kattan T; Gentzsch J; Kress AK; Taylor GP; Bangham CRM; Grassmann R. (1 May 2008). Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral tax oncoprotein. BLOOD. 111:4741-4751. Author weblink DOI.
  • Majorovits E; Nejmeddine M; Tanaka Y; Taylor GP; Fuller SD; Bangham CR. (2008). Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLOS One. 3:-e2251.
  • Bangham CRM; Asquith B. (9 Feb 2001). Virus dynamics - Mathematical principles of immunology and virology. SCIENCE. 291:992-992. Author weblink.
  • Schonbach C; Nokihara K; Bangham CRM; Kariyone A; Karaki S; Shida H; Takatsu K; Egawa K; et alWiesmuller KH; Takiguchi M. (1 Dec 1996). Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice. VIROLOGY. 226:102-112. DOI.
  • Toulza F; Nosaka K; Tanaka Y; Schioppa T; Balkwill F; Taylor GP; Bangham CR. (1 Jul 2010). Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol. 185:183-189. DOI.
  • Modolell M; Choi BS; Ryan RO; Hancock M; Titus RG; Abebe T; Hailu A; Müller I; et alRogers ME; Bangham CR; Munder M; Kropf P. (2009). Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis. PLoS Negl Trop Dis. 3:e480. DOI.
  • Bangham CR. (Jul 2009). CTL quality and the control of human retroviral infections. Eur J Immunol. 39:1700-1712. DOI.
  • Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR. (15 Nov 2009). FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int J Cancer. 125:2375-2382. DOI.
  • Nejmeddine M; Negi VS; Mukherjee S; Tanaka Y; Orth K; Taylor GP; Bangham CR. (30 Jul 2009). HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood. 114:1016-1025. DOI.
  • Kattan T; MacNamara A; Rowan AG; Nose H; Mosley AJ; Tanaka Y; Taylor GP; Asquith B; et alBangham CR. (1 May 2009). The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol. 182:5723-5729. DOI.
  • MacNamara A; Kadolsky U; Bangham CR; Asquith B. (Mar 2009). T-cell epitope prediction: rescaling can mask biological variation between MHC molecules. PLoS Comput Biol. 5:e1000327. DOI.
  • Bangham CR; Meekings K; Toulza F; Nejmeddine M; Majorovits E; Asquith B; Taylor GP. (2009). The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci. 14:2889-2903.
  • Bangham CR. (15 Sep 2008). HTLV-1 infection: role of CTL efficiency. Blood. 112:2176-2177. DOI.
  • Majorovits E; Nejmeddine M; Tanaka Y; Taylor GP; Fuller SD; Bangham CR. (2008). Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS One. 3:e2251. DOI.
  • Meekings KN; Leipzig J; Bushman FD; Taylor GP; Bangham CR. (Mar 2008). HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 4:e1000027. DOI.
  • Pichler K; Kattan T; Gentzsch J; Kress AK; Taylor GP; Bangham CR; Grassmann R. (1 May 2008). Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein. Blood. 111:4741-4751. DOI.
  • Asquith B; Bangham CR. (Jan 2008). How does HTLV-I persist despite a strong cell-mediated immune response?. Trends Immunol. 29:4-11. DOI.
  • Toulza F; Heaps A; Tanaka Y; Taylor GP; Bangham CR. (15 May 2008). High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 111:5047-5053. DOI.
  • Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; et alWucherpfennig KW; Bangham CR; Osame M; Saito M. (15 Dec 2007). Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide. J Infect Dis. 196:1761-1772. DOI.
  • Asquith B; Bangham CR. (Jun 2007). Quantifying HTLV-I dynamics. Immunol Cell Biol. 85:280-286. DOI.
  • Asquith B; Zhang Y; Mosley AJ; de Lara CM; Wallace DL; Worth A; Kaftantzi L; Meekings K; et alGriffin GE; Tanaka Y; Tough DF; Beverley PC; Taylor GP; Macallan DC; Bangham CR. (8 May 2007). In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A. 104:8035-8040. DOI.
  • Kropf P; Baud D; Marshall SE; Munder M; Mosley A; Fuentes JM; Bangham CR; Taylor GP; et alHerath S; Choi BS; Soler G; Teoh T; Modolell M; Müller I. (Apr 2007). Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol. 37:935-945. DOI.
  • Chiu C; Heaps AG; Cerundolo V; McMichael AJ; Bangham CR; Callan MF. (1 Feb 2007). Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo. Blood. 109:1086-1094. DOI.
  • Mosley AJ; Meekings KN; McCarthy C; Shepherd D; Cerundolo V; Mazitschek R; Tanaka Y; Taylor GP; et alBangham CR. (1 Dec 2006). Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection. Blood. 108:3801-3807. DOI.
  • Nobuhara Y; Usuku K; Saito M; Izumo S; Arimura K; Bangham CR; Osame M. (Jan 2006). Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease. Immunogenetics. 57:944-952. DOI.
  • Taylor GP; Goon P; Furukawa Y; Green H; Barfield A; Mosley A; Nose H; Babiker A; et alRudge P; Usuku K; Osame M; Bangham CR; Weber JN. (2006). Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. Retrovirology. 3:63. DOI.
  • Bangham CR; Osame M. (5 Sep 2005). Cellular immune response to HTLV-1. Oncogene. 24:6035-6046. DOI.
  • Nejmeddine M; Barnard AL; Tanaka Y; Taylor GP; Bangham CR. (19 Aug 2005). Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J Biol Chem. 280:29653-29660. DOI.
  • Barnard AL; Igakura T; Tanaka Y; Taylor GP; Bangham CR. (1 Aug 2005). Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood. 106:988-995. DOI.
  • Asquith B; Mosley AJ; Barfield A; Marshall SE; Heaps A; Goon P; Hanon E; Tanaka Y; et alTaylor GP; Bangham CR. (May 2005). A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol. 86:1515-1523. DOI.
  • Mosley AJ; Asquith B; Bangham CR. (2005). Cell-mediated immune response to human T-lymphotropic virus type I. Viral Immunol. 18:293-305. DOI.
  • Asquith B; Mosley AJ; Heaps A; Tanaka Y; Taylor GP; McLean AR; Bangham CR. (2005). Quantification of the virus-host interaction in human T lymphotropic virus I infection. Retrovirology. 2:75. DOI.
  • Kodama D; Saito M; Matsumoto W; Sabouri AH; Izumo S; Arimura K; Usuku K; Bangham CR; et alOsame M. (Nov 2004). Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neuroimmunol. 156:188-194. DOI.
  • Vine AM; Heaps AG; Kaftantzi L; Mosley A; Asquith B; Witkover A; Thompson G; Saito M; et alGoon PK; Carr L; Martinez-Murillo F; Taylor GP; Bangham CR. (15 Oct 2004). The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol. 173:5121-5129.
  • Sabouri AH; Saito M; Lloyd AL; Vine AM; Witkover AW; Furukawa Y; Izumo S; Arimura K; et alMarshall SE; Usuku K; Bangham CR; Osame M. (1 Oct 2004). Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 190:1279-1285. DOI.
  • Goon PK; Bangham CR. (Aug 2004). Interference with immune function by HTLV-1. Clin Exp Immunol. 137:234-236. DOI.
  • Goon PK; Biancardi A; Fast N; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; et alMarshall S; Taylor GP; Bangham CR. (15 Jun 2004). Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis. 189:2294-2298. DOI.
  • Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; et alTaylor GP; Weber JN; Bangham CR. (1 Feb 2004). Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol. 172:1735-1743.
  • Chung HK; Young HA; Goon PK; Heidecker G; Princler GL; Shimozato O; Taylor GP; Bangham CR; et alDerse D. (1 Dec 2003). Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood. 102:4130-4136. DOI.
  • Bangham CR. (Dec 2003). The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol. 84:3177-3189.
  • Davis DM; Igakura T; McCann FE; Carlin LM; Andersson K; Vanherberghen B; Sjöström A; Bangham CR; et alHöglund P. (Dec 2003). The protean immune cell synapse: a supramolecular structure with many functions. Semin Immunol. 15:317-324. DOI.
  • Bangham CR. (Nov 2003). Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int J Hematol. 78:297-303.
  • Goon PK; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Taylor GP; Weber JN; et alBangham CR. (Sep 2003). High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease. J Virol. 77:9716-9722.
  • Asquith B; Bangham CR. (22 Aug 2003). An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis. Proc Biol Sci. 270:1651-1657. DOI.
  • Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; et alUsuku K; Weber JN; Osame M; Bangham CR. (15 Jul 2003). Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers. Blood. 102:577-584. DOI.
  • Asquith B; Bangham CR. (7 May 2003). The dynamics of T-cell fratricide: application of a robust approach to mathematical modelling in immunology. J Theor Biol. 222:53-69.
  • Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; et alBangham CR. (14 Mar 2003). Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science. 299:1713-1716. DOI.
  • Asquith B; Debacq C; Macallan DC; Willems L; Bangham CR. (Dec 2002). Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol. 23:596-601.
  • Saito M; Higuchi I; Saito A; Izumo S; Usuku K; Bangham CR; Osame M. (1 Nov 2002). Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis. 186:1231-1241. DOI.
  • Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; et alIzumo S; Usuku K; Osame M; Bangham CR. (1 Oct 2002). Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 186:932-939. DOI.
  • Goon PK; Hanon E; Igakura T; Tanaka Y; Weber JN; Taylor GP; Bangham CR. (1 May 2002). High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood. 99:3335-3341.
  • Lomas M; Hanon E; Tanaka Y; Bangham CR; Gould KG. (Mar 2002). Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin. J Gen Virol. 83:641-650.
  • Hanon E; Goon P; Taylor GP; Hasegawa H; Tanaka Y; Weber JN; Bangham CR. (1 Aug 2001). High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood. 98:721-726.
  • Wodarz D; Hall SE; Usuku K; Osame M; Ogg GS; McMichael AJ; Nowak MA; Bangham CR. (22 Jun 2001). Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci. 268:1215-1221. DOI.
  • Overbaugh J; Bangham CR. (11 May 2001). Selection forces and constraints on retroviral sequence variation. Science. 292:1106-1109.
  • Saito M; Taylor GP; Saito A; Furukawa Y; Usuku K; Weber JN; Osame M; Bangham CR. (Jan 2001). In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes. J Virol. 75:1065-1071. DOI.
  • Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; et alWelsh KI; Osame M; Bangham CR. (15 Dec 2000). The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol. 165:7278-7284.
  • Asquith B; Bangham CR. (7 Nov 2000). The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. J Theor Biol. 207:65-79. DOI.
  • Hanon E; Stinchcombe JC; Saito M; Asquith BE; Taylor GP; Tanaka Y; Weber JN; Griffiths GM; et alBangham CR. (Nov 2000). Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 13:657-664.
  • Hanon E; Asquith RE; Taylor GP; Tanaka Y; Weber JN; Bangham CR. (1 Nov 2000). High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses. 16:1711-1715. DOI.
  • Jeffery KJ; Bangham CR. (Sep 2000). Do infectious diseases drive MHC diversity?. Microbes Infect. 2:1335-1341.
  • Asquith B; Hanon E; Taylor GP; Bangham CR. (29 Aug 2000). Is human T-cell lymphotropic virus type I really silent?. Philos Trans R Soc Lond B Biol Sci. 355:1013-1019. DOI.
  • Bangham CR. (Aug 2000). HTLV-1 infections. J Clin Pathol. 53:581-586.
  • Bangham CR. (Aug 2000). The immune response to HTLV-I. Curr Opin Immunol. 12:397-402.
  • Wodarz D; Bangham CR. (May 2000). Evolutionary dynamics of HTLV-I. J Mol Evol. 50:448-455.
  • Furukawa Y; Bangham CR; Taylor GP; Weber JN; Osame M. (May 2000). Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Clin Exp Immunol. 120:307-316.
  • Phillips RE; Oxenius A; Price DA; Bangham CR. (Apr 2000). AIDS: the evolving story. Trends Microbiol. 8:147-148.
  • Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; et alWeber JN; Bangham CR. (15 Feb 2000). Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 95:1386-1392.
  • Taylor GP; Hall SE; Navarrete S; Michie CA; Davis R; Witkover AD; Rossor M; Nowak MA; et alRudge P; Matutes E; Bangham CR; Weber JN. (Dec 1999). Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol. 73:10289-10295.
  • Taylor GP; Tosswill JH; Matutes E; Daenke S; Hall S; Bain BJ; Davis R; Thomas D; et alRossor M; Bangham CR; Weber JN. (1 Sep 1999). Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 22:92-100.
  • Wodarz D; Nowak MA; Bangham CR. (May 1999). The dynamics of HTLV-I and the CTL response. Immunol Today. 20:220-227.
  • Bangham CR; Hall SE; Jeffery KJ; Vine AM; Witkover A; Nowak MA; Wodarz D; Usuku K; et alOsame M. (29 Apr 1999). Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. Philos Trans R Soc Lond B Biol Sci. 354:691-700. DOI.
  • Jeffery KJ; Usuku K; Hall SE; Matsumoto W; Taylor GP; Procter J; Bunce M; Ogg GS; et alWelsh KI; Weber JN; Lloyd AL; Nowak MA; Nagai M; Kodama D; Izumo S; Osame M; Bangham CR. (30 Mar 1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A. 96:3848-3853.
  • Nagai M; Usuku K; Matsumoto W; Kodama D; Takenouchi N; Moritoyo T; Hashiguchi S; Ichinose M; et alBangham CR; Izumo S; Osame M. (Dec 1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 4:586-593.
  • Gould KG; Bangham CR. (Jun 1998). Virus variation, escape from cytotoxic T lymphocytes and human retroviral persistence. Semin Cell Dev Biol. 9:321-328. DOI.
  • Hawke S; Stevenson PG; Freeman S; Bangham CR. (18 May 1998). Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med. 187:1575-1582.
  • Dégano P; Sarphie DF; Bangham CR. (Feb 1998). Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. Vaccine. 16:394-398.
  • Stevenson PG; Bangham CR; Hawke S. (Dec 1997). Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site. Eur J Immunol. 27:3259-3268. DOI.
  • Bangham CR; Phillips RE. (29 Nov 1997). What is required of an HIV vaccine?. Lancet. 350:1617-1621. DOI.
  • Smith RE; Niewiesk S; Booth S; Bangham CR; Daenke S. (27 Oct 1997). Functional conservation of HTLV-1 rex balances the immune pressure for sequence variation in the rex gene. Virology. 237:397-403. DOI.
  • Stevenson PG; Freeman S; Bangham CR; Hawke S. (15 Aug 1997). Virus dissemination through the brain parenchyma without immunologic control. J Immunol. 159:1876-1884.
  • Stevenson PG; Hawke S; Bangham CR. (26 May 1997). Protection against influenza virus encephalitis by adoptive lymphocyte transfer. Virology. 232:158-166. DOI.
  • Price DA; Goulder PJ; Klenerman P; Sewell AK; Easterbrook PJ; Troop M; Bangham CR; Phillips RE. (4 Mar 1997). Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A. 94:1890-1895.
  • Read SJ; Jeffery KJ; Bangham CR. (Mar 1997). Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol. 35:691-696.
  • Jeffery KJ; Read SJ; Peto TE; Mayon-White RT; Bangham CR. (1 Feb 1997). Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet. 349:313-317. DOI.
  • Stevenson PG; Hawke S; Sloan DJ; Bangham CR. (Jan 1997). The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol. 71:145-151.
  • Schönbach C; Nokihara K; Bangham CR; Kariyone A; Karaki S; Shida H; Takatsu K; Egawa K; et alWiesmüller KH; Takiguchi M. (1 Dec 1996). Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice. Virology. 226:102-112. DOI.
  • Stevenson PG; Hawke S; Bangham CR. (1 Oct 1996). Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells. J Immunol. 157:3065-3073.
  • Nowak MA; Bangham CR. (5 Apr 1996). Population dynamics of immune responses to persistent viruses. Science. 272:74-79.
  • Niewiesk S; Bangham CR. (Apr 1996). Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis. J Mol Evol. 42:452-458.
  • Daenke S; Kermode AG; Hall SE; Taylor G; Weber J; Nightingale S; Bangham CR. (1 Mar 1996). High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology. 217:139-146. DOI.
  • Nowak MA; May RM; Phillips RE; Rowland-Jones S; Lalloo DG; McAdam S; Klenerman P; Köppe B; et alSigmund K; Bangham CR. (15 Jun 1995). Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature. 375:606-611. DOI.
  • Niewiesk S; Daenke S; Parker CE; Taylor G; Weber J; Nightingale S; Bangham CR. (Apr 1995). Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol. 69:2649-2653.
  • Anderson LJ; Tsou C; Potter C; Keyserling HL; Smith TF; Ananaba G; Bangham CR. (Nov 1994). Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis. 170:1201-1208.
  • Niewiesk S; Daenke S; Parker CE; Taylor G; Weber J; Nightingale S; Bangham CR. (Oct 1994). The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol. 68:6778-6781.
  • Daenke S; Schramm HJ; Bangham CR. (Sep 1994). Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding. J Gen Virol. 75 ( Pt 9):2233-2239.
  • Kirkwood TB; Bangham CR. (30 Aug 1994). Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. Proc Natl Acad Sci U S A. 91:8685-8689.
  • Parker CE; Nightingale S; Taylor GP; Weber J; Bangham CR. (May 1994). Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol. 68:2860-2868.
  • Daenke S; Bangham CR. (May 1994). Do T cells cause HTLV-1-associated disease?: a taxing problem. Clin Exp Immunol. 96:179-181.
  • Daenke S; Parker CE; Niewiesk S; Newsom-Davis J; Nightingale S; Bangham CR. (Apr 1994). Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I. J Infect Dis. 169:941-943.
  • Bangham CR; Kirkwood TB. (Oct 1993). Defective interfering particles and virus evolution. Trends Microbiol. 1:260-264.
  • Bangham CR. (Oct 1993). Human T-cell leukaemia virus type I and neurological disease. Curr Opin Neurobiol. 3:773-778.
  • Screaton GR; Bangham CR; Bell JI. (11 May 1993). Direct sequencing of single primer PCR products: a rapid method to achieve short chromosomal walks. Nucleic Acids Res. 21:2263-2264.
  • Bangham CR. (Apr 1993). Retrovirus infections of the nervous system. Curr Opin Neurol Neurosurg. 6:176-181.
  • Rowland-Jones SL; Phillips RE; Nixon DF; Gotch FM; Edwards JP; Ogunlesi AO; Elvin JG; Rothbard JA; et alBangham CR; Rizza CR. (Aug 1992). Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. AIDS Res Hum Retroviruses. 8:1353-1354.
  • Parker CE; Daenke S; Nightingale S; Bangham CR. (Jun 1992). Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology. 188:628-636.
  • Phillips RE; Rowland-Jones S; Nixon DF; Gotch FM; Edwards JP; Ogunlesi AO; Elvin JG; Rothbard JA; et alBangham CR; Rizza CR. (12 Dec 1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354:453-459. DOI.
  • Bangham CR; Kirkwood TB. (Dec 1990). Defective interfering particles: effects in modulating virus growth and persistence. Virology. 179:821-826.
  • Bangham CR; McMichael AJ. (29 Nov 1990). HIV infection. Why the long latent period?. Nature. 348:388. DOI.
  • Daenke S; Nightingale S; Cruickshank JK; Bangham CR. (Mar 1990). Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol. 64:1278-1282.
  • Bangham CR; McMichael AJ. (1 Mar 1990). Virology. Nosing ahead in the cold war. Nature. 344:16. DOI.
  • Cannon MJ; Bangham CR. (Jan 1989). Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line. J Gen Virol. 70 ( Pt 1):79-87.
  • Bangham CR; Daenke S; Phillips RE; Cruickshank JK; Bell JI. (20 Dec 1988). Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis. EMBO J. 7:4179-4184.
  • Bangham CR; Bushell A; Wood KJ; Morris PJ. (Feb 1988). An interactive computer program for the analysis of HLA class II restriction fragment patterns. Hum Immunol. 21:125-132.
  • Isaacs D; Bangham CR; McMichael AJ. (3 Oct 1987). Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet. 2:769-771.
  • Bangham CR; Openshaw PJ; Ball LA; King AM; Wertz GW; Askonas BA. (15 Dec 1986). Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol. 137:3973-3977.
  • Bangham CR; McMichael AJ. (Dec 1986). Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci U S A. 83:9183-9187.
  • Bangham CR. (Sep 1986). Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse. Immunology. 59:37-41.
  • Bangham CR; Askonas BA. (Apr 1986). Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. J Gen Virol. 67 ( Pt 4):623-629.
  • Bangham CR; Cannon MJ; Karzon DT; Askonas BA. (Oct 1985). Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol. 56:55-59.
  • Bangham CR; Hope RA. (May 1981). Exercise-induced asthma in Nepalese children. Clin Allergy. 11:273-280.
  • Hope RA; Bangham CR. (May 1981). The prevalence of immediate positive skin tests in Nepalese children. Clin Allergy. 11:263-271.
  • Bangham CR; Howarth SE. (Sep 1980). Genetic polymorphisms in isolated Sherpa populations of Nepal. Am J Phys Anthropol. 53:369-373. DOI.
  • Bangham CR; Sacherer JM. (Jul 1980). Fertility of Nepalese Sherpas at moderate altitudes: comparison with high-altitude data. Ann Hum Biol. 7:323-330.
  • Bangham CR; Hackett PH. (Oct 1978). Effects of high altitude on endocrine function in the Sherpas of Nepal. J Endocrinol. 79:147-148.
  • Bangham CR; Veale KE. (Feb 1977). Ventilatory capacity in healthy Neplasese [proceedings]. J Physiol. 265:31P-32P.

Chapters in books

  • Bangham CRM. HTLV-1. In Encyclopedia of Life Sciences. (2011). Publisher weblink.
  • Bangham CRM. Genetics and dynamics of the immune response to HTLV-I. In Gann Monograph on Cancer Research. 149-170. Karger, Basel (2003).

Conferences

  • Tattermusch S; Skinner J; Chaussabel D; Banchereau J; Berry M; O'Garra A; Taylor G; Bangham C. An interferon signature is associated with disease but not viral containment in chronic infection with the human T-cell lymphotropic virus type 1. Annual Congress of the British-Society-for-Immunology, 6 Dec 2010 - 10 Dec 2010. 131:188-188. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2010). Author weblink.
  • Ferreira AF; Rowan A; Bangham CR; Taylor G. Quantification of CD8+ T Cell Responses to HTLV-1: Balance of inflammatory and Antiviral Effects. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1286-1286. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Hlela C; Bangham CR; Graham OGG; Taylor G; Marafioti T. South African individuals with Human T-Lymphotropic Virus Type 1 (HTLV-1) Associated Infective Dermatitis do not have an Atopic Diathesis. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1279-1279. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Chiu C; Bangham CR; McMichael AJ; Callan MFC. An analysis of the events involved in the differentiation of naive CD8+T cells during a primary immune response in vivo. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops. 66:379-380. (Nov 2005).
  • Chung H; Derse D; Bangham CR. Activation of interleukin-13 expression in HTLV-1 infected T-cells in vivo and in vitro. 11th International Conference on Human Retrovirology: HTLV and Related Viruses, 9 Jun 2003 - 12 Jun 2003. 19:S53-S53. MARY ANN LIEBERT INC PUBL (1 Jan 2003). Author weblink.
  • Nobuhara Y; Usuku K; Saito M; Izumo S; Bangham CR; Osame M. Analyzing polymorphism of Aggrecan and level of Aggrecan in CSF in HTLV-I virus infected patients. 11th International Conference on Human Retrovirology: HTLV and Related Viruses, 9 Jun 2003 - 12 Jun 2003. 19:S42-S42. MARY ANN LIEBERT INC PUBL (1 Jan 2003). Author weblink.
  • Asquith BE; Mosley AJ; Goon PK; Heaps AG; Biancardi A; Barfield A; Vine AM; Taylor GP; et alBangham CR. Does the CTL response determine HTLV-I equilibrium proviral load?. 11th International Conference on Human Retrovirology: HTLV and Related Viruses, 9 Jun 2003 - 12 Jun 2003. 19:S38-S38. MARY ANN LIEBERT INC PUBL (1 Jan 2003). Author weblink.
  • Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; et alBangham CR. HTLV-I spreads between lymphocytes by virus-induced polarization of the cytoskeleton. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S15-S15. (2003).
  • Goon PK; Taylor GP; Bangham CR. HTLV-I-specific CD4+ T cells: Immunodominance hierarchy and preferential infection with HTLV-I. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S9-S9. (2003).
  • Usuku K; Saito M; Nobuhara Y; Izumo S; Bangham CR; Osame M. Low provirus load and high neopterin amount in patients with HLA-DRBL*0101 positive HAM-low virus burden is sufficient to elicit inflammation. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S11-S12. (2003).
  • Nejmeddine M; Barnard AL; Goon P; Taylor GP; Igakura T; Bangham CR. Mechanisms involved in the spread of HTLV-1 between lymphocytes. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S37-S37. (2003).
  • Saito M; Hanada K; Kodama D; Asquith B; Izumo S; Usuku K; Gojobori T; Bangham CR; et alOsame M. Naturally occurring mutations of HTLV-1 proviral genome within HAM/TSP patients and asymptomatic carriers; Relationship between proviral load, host genotype and disease state. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S60-S60. (2003).
  • Taylor GP; Goon P; Usuku K; Barfield A; Green H; Babiker A; Bangham CR; Weber JN. The bridge study - A double-blind placebo controlled trial of zidovudine plus lamivudine for treatment of patients with HTLV-I-associated myelopathy. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S13-S14. (2003).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook